ArticleCancers2021

Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells.

Maria Maddalena Laterza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.